Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 51.05 M51.1 M — Research & development —— — Operating income -325.58 M81.02 M — Non-Operating Income, Total -160.42 M72.07 M — Interest expense, net of interest capitalized 344 K354 K — Non-Operating Income, excl. Interest Expenses -153.23 M70.72 M — Unusual income/expense -7.54 M993 K — Pretax income -486 M153.09 M — Equity in earnings —— — Taxes -3.9 M-61.29 M — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 352.52 M-343.97 M — Discontinued operations —— — Net income 352.52 M-343.97 M — Dilution adjustment -834.62 M513.56 M — Preferred dividends 00 — Diluted net income available to common stockholders -482.1 M169.6 M — Basic earnings per share (Basic EPS) -4.480.93 — Diluted earnings per share (Diluted EPS) -4.480.64 — Average basic shares outstanding 82.88 M132.42 M — Diluted shares outstanding 82.88 M132.42 M — EBITDA 95.09 M551.25 M — EBIT 80.89 M528.22 M — Cost of revenue 470 K413 K — Other cost of goods sold —— — Depreciation & amortization (cash flow) 14.2 M23.03 M —